Ventyx Biosciences Inc.

NASDAQ: VTYX · Real-Time Price · USD
2.85
-0.15 (-5.00%)
At close: Aug 15, 2025, 3:59 PM
2.88
1.18%
After-hours: Aug 15, 2025, 06:58 PM EDT

Ventyx Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
1.35M 941K 470K 30K
Gross Profit
-1.35M -941K -470K -30K
Operating Income
-148.45M -207.99M -113.14M -67.15M
Interest Income
13.42M 15.07M 4.67M 78K
Pretax Income
-135.12M -192.96M -108.43M -83.75M
Net Income
-135.12M -192.96M -107.96M -83.75M
Selling & General & Admin
31.45M 32.23M 25.4M 8.67M
Research & Development
117M 175.77M 87.74M 58.48M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
148.45M 207.99M 113.14M 67.15M
Interest Expense
n/a n/a n/a 99K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
148.45M 207.99M 113.14M 67.15M
Income Tax Expense
n/a n/a -470K n/a
Shares Outstanding (Basic)
68.48M 58.54M 52.47M 50.41M
Shares Outstanding (Diluted)
68.48M 58.54M 52.47M 50.41M
EPS (Basic)
-1.97 -3.3 -2.06 -1.69
EPS (Diluted)
-1.97 -3.3 -2.06 -1.69
EBITDA
-133.77M -207.84M -107.96M -67.12M
EBIT
-135.12M -207.99M -108.43M -67.15M
Depreciation & Amortization
1.35M 158K 470K 30K